Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency

PLoS Biology

Volumn 9, Issue 11, 2011, Pages

  Rafati, Haleh ^a   Parra, Maribel ^b,c   Hakre, Shweta ^b   Moshkin, Yuri ^a   Verdin, Eric ^b   Mahmoudi, Tokameh ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; DEOXYRIBONUCLEASE; HISTONE; PROTEIN SWI; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SNF; VIRUS DNA; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; NONHISTONE PROTEIN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LEUKEMIA CELL LINE; LIFE CYCLE; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOSOME; PROMOTER REGION; PROTEIN DEPLETION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; VIRUS LATENCY; ACETYLATION; BIOLOGICAL MODEL; CHROMATIN ASSEMBLY AND DISASSEMBLY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY; VIRUS ACTIVATION;

ACETYLATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; GENE EXPRESSION REGULATION, VIRAL; HIV LONG TERMINAL REPEAT; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; JURKAT CELLS; MODELS, GENETIC; NUCLEOSOMES; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTIONAL ACTIVATION; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 82455219436     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001206     Document Type: Article

References (72)

1. Chun T. W, Stuyver L, Mizell S. B, Ehler L. A, Mican J. A, et al. (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 94: 13193-13197.
2. Finzi D, Hermankova M, Pierson T, Carruth L. M, Buck C, et al. (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278: 1295-1300.
3. Wong J. K, Hezareh M, Gunthard H. F, Havlir D. V, Ignacio C. C, et al. (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278: 1291-1295.
4. Siliciano J. D, Siliciano R. F, (2006) The latent reservoir for HIV-1 in resting CD4+T cells: a barrier to cure. Curr Opin HIV AIDS 1: 121-128.
5. Verdin E, Paras P Jr, Van Lint C, (1993) Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 12: 3249-3259.
6. Verdin E, (1991) DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J Virol 65: 6790-6799.
7. Van Lint C, Emiliani S, Ott M, Verdin E, (1996) Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 15: 1112-1120.
8. Demarchi F, D'Agaro P, Falaschi A, Giacca M, (1993) In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J Virol 67: 7450-7460.
9. Coull J. J, Romerio F, Sun J. M, Volker J. L, Galvin K. M, et al. (2000) The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 74: 6790-6799.
10. Williams S. A, Chen L. F, Kwon H, Ruiz-Jarabo C. M, Verdin E, et al. (2006) NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 25: 139-149.
11. Jiang G, Espeseth A, Hazuda D. J, Margolis D. M, (2007) c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 81: 10914-10923.
12. Sheridan P. L, Mayall T. P, Verdin E, Jones K. A, (1997) Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev 11: 3327-3340.
13. Lusic M, Marcello A, Cereseto A, Giacca M, (2003) Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J 22: 6550-6561.
14. Easley R, Van Duyne R, Coley W, Guendel I, Dadgar S, et al. (2010) Chromatin dynamics associated with HIV-1 Tat-activated transcription. Biochim Biophys Acta 1799: 275-285.
15. Karn J, (1999) Tackling Tat. J Mol Biol 293: 235-254.
16. Ho L, Crabtree G. R, (2010) Chromatin remodelling during development. Nature 463: 474-484.
17. Hargreaves D. C, Crabtree G. R, (2011) ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res 21: 396-420.
18. de la Serna I. L, Ohkawa Y, Imbalzano A. N, (2006) Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat Rev Genet 7: 461-473.
19. Klochendler-Yeivin A, Muchardt C, Yaniv M, (2002) SWI/SNF chromatin remodeling and cancer. Curr Opin Genet Dev 12: 73-79.
20. Wang W, Cote J, Xue Y, Zhou S, Khavari P. A, et al. (1996) Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 15: 5370-5382.
21. Wang W, Xue Y, Zhou S, Kuo A, Cairns B. R, et al. (1996) Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 10: 2117-2130.
22. Katsani K. R, Mahmoudi T, Verrijzer C. P, (2003) Selective gene regulation by SWI/SNF-related chromatin remodeling factors. Curr Top Microbiol Immunol 274: 113-141.
23. Xue Y, Canman J. C, Lee C. S, Nie Z, Yang D, et al. (2000) The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci U S A 97: 13015-13020.
24. Lemon B, Inouye C, King D. S, Tjian R, (2001) Selectivity of chromatin-remodelling cofactors for ligand-activated transcription. Nature 414: 924-928.
25. Chalkley G. E, Moshkin Y. M, Langenberg K, Bezstarosti K, Blastyak A, et al. (2008) The transcriptional coactivator SAYP is a trithorax group signature subunit of the PBAP chromatin remodeling complex. Mol Cell Biol 28: 2920-2929.
26. Yan Z, Cui K, Murray D. M, Ling C, Xue Y, et al. (2005) PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev 19: 1662-1667.
27. Kaeser M. D, Aslanian A, Dong M. Q, Yates J. R 3rd, Emerson B. M, (2008) BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem 283: 32254-32263.
28. Nie Z, Xue Y, Yang D, Zhou S, Deroo B. J, et al. (2000) A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol 20: 8879-8888.
29. Nagl N. G Jr, Wang X, Patsialou A, Van Scoy M, Moran E, (2007) Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J 26: 752-763.
30. Hsiao P. W, Fryer C. J, Trotter K. W, Wang W, Archer T. K, (2003) BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation. Mol Cell Biol 23: 6210-6220.
31. Inoue H, Furukawa T, Giannakopoulos S, Zhou S, King D. S, et al. (2002) Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors. J Biol Chem 277: 41674-41685.
32. Moshkin Y. M, Mohrmann L, van Ijcken W. F, Verrijzer C. P, (2007) Functional differentiation of SWI/SNF remodelers in transcription and cell cycle control. Mol Cell Biol 27: 651-661.
33. Collins R. T, Treisman J. E, (2000) Osa-containing Brahma chromatin remodeling complexes are required for the repression of wingless target genes. Genes Dev 14: 3140-3152.
34. Mohrmann L, Langenberg K, Krijgsveld J, Kal A. J, Heck A. J, et al. (2004) Differential targeting of two distinct SWI/SNF-related Drosophila chromatin-remodeling complexes. Mol Cell Biol 24: 3077-3088.
35. El Kharroubi A, Piras G, Zensen R, Martin M. A, (1998) Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol Cell Biol 18: 2535-2544.
36. Agbottah E, Deng L, Dannenberg L. O, Pumfery A, Kashanchi F, (2006) Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription. Retrovirology 3: 48.
37. Ariumi Y, Serhan F, Turelli P, Telenti A, Trono D, (2006) The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription. Retrovirology 3: 47.
38. Mahmoudi T, Parra M, Vries R. G, Kauder S. E, Verrijzer C. P, et al. (2006) The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J Biol Chem 281: 19960-19968.
39. Treand C, du Chene I, Bres V, Kiernan R, Benarous R, et al. (2006) Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J 25: 1690-1699.
40. Mizutani T, Ishizaka A, Tomizawa M, Okazaki T, Yamamichi N, et al. (2009) Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts. J Virol 83: 11569-11580.
41. Kalpana G. V, Marmon S, Wang W, Crabtree G. R, Goff S. P, (1994) Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266: 2002-2006.
42. Maroun M, Delelis O, Coadou G, Bader T, Segeral E, et al. (2006) Inhibition of early steps of HIV-1 replication by SNF5/Ini1. J Biol Chem 281: 22736-22743.
43. Boese A, Sommer P, Holzer D, Maier R, Nehrbass U, (2009) Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity. J Gen Virol 90: 2503-2512.
44. Lesbats P, Botbol Y, Chevereau G, Vaillant C, Calmels C, et al. (2011) Functional coupling between HIV-1 integrase and the SWI/SNF chromatin remodeling complex for efficient in vitro integration into stable nucleosomes. PLoS Pathog 7: e1001280 doi:10.1371/journal.ppat.1001280.
45. Jordan A, Defechereux P, Verdin E, (2001) The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 20: 1726-1738.
46. Jordan A, Bisgrove D, Verdin E, (2003) HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 22: 1868-1877.
47. Cismasiu V. B, Paskaleva E, Suman Daya S, Canki M, Duus K, et al. (2008) BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. Virology 380: 173-181.
48. Kauder S. E, Bosque A, Lindqvist A, Planelles V, Verdin E, (2009) Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 5: e1000495 doi:10.1371/journal.ppat.1000495.
49. Vanti M, Gallastegui E, Respaldiza I, Rodriguez-Gil A, Gomez-Herreros F, et al. (2009) Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription. PLoS Genet 5: e1000339 doi:10.1371/journal.pgen.1000339.
50. Turelli P, Doucas V, Craig E, Mangeat B, Klages N, et al. (2001) Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol Cell 7: 1245-1254.
51. Nie Z, Yan Z, Chen E. H, Sechi S, Ling C, et al. (2003) Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol Cell Biol 23: 2942-2952.
52. Easley R, Carpio L, Dannenberg L, Choi S, Alani D, et al. (2010) Transcription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcription. Virology 405: 322-333.
53. Deng L, Wang D, de la Fuente C, Wang L, Li H, et al. (2001) Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. Virology 289: 312-326.
54. Aguilar-Cordova E, Chinen J, Donehower L, Lewis D. E, Belmont J. W, (1994) A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res Hum Retroviruses 10: 295-301.
55. Xi L, Fondufe-Mittendorf Y, Xia L, Flatow J, Widom J, et al. (2010) Predicting nucleosome positioning using a duration Hidden Markov Model. BMC Bioinformatics 11: 346.
56. Kaplan N, Moore I. K, Fondufe-Mittendorf Y, Gossett A. J, Tillo D, et al. (2009) The DNA-encoded nucleosome organization of a eukaryotic genome. Nature 458: 362-366.
57. Segal E, Fondufe-Mittendorf Y, Chen L, Thastrom A, Field Y, et al. (2006) A genomic code for nucleosome positioning. Nature 442: 772-778.
58. Brady T, Agosto L. M, Malani N, Berry C. C, O'Doherty U, et al. (2009) HIV integration site distributions in resting and activated CD4+T cells infected in culture. AIDS 23: 1461-1471.
59. Sekinger E. A, Moqtaderi Z, Struhl K, (2005) Intrinsic histone-DNA interactions and low nucleosome density are important for preferential accessibility of promoter regions in yeast. Mol Cell 18: 735-748.
60. Petesch S. J, Lis J. T, (2008) Rapid, transcription-independent loss of nucleosomes over a large chromatin domain at Hsp70 loci. Cell 134: 74-84.
61. Duverger A, Jones J, May J, Bibollet-Ruche F, Wagner F. A, et al. (2009) Determinants of the establishment of human immunodeficiency virus type 1 latency. J Virol 83: 3078-3093.
62. Ott M, Schnolzer M, Garnica J, Fischle W, Emiliani S, et al. (1999) Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol 9: 1489-1492.
63. Kiernan R. E, Vanhulle C, Schiltz L, Adam E, Xiao H, et al. (1999) HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J 18: 6106-6118.
64. Benkirane M, Chun R. F, Xiao H, Ogryzko V. V, Howard B. H, et al. (1998) Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 273: 24898-24905.
65. Marzio G, Tyagi M, Gutierrez M. I, Giacca M, (1998) HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc Natl Acad Sci U S A 95: 13519-13524.
66. Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, et al. (2000) Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 277: 278-295.
67. Kim J. Y, Gonzalez-Scarano F, Zeichner S. L, Alwine J. C, (1993) Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J Virol 67: 1658-1662.
68. Steger D. J, Workman J. L, (1997) Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. EMBO J 16: 2463-2472.
69. He G, Margolis D. M, (2002) Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol 22: 2965-2973.
70. Mohd-Sarip A, Venturini F, Chalkley G. E, Verrijzer C. P, (2002) Pleiohomeotic can link polycomb to DNA and mediate transcriptional repression. Mol Cell Biol 22: 7473-7483.
71. Subtil-Rodriguez A, Reyes J. C, (2010) BRG1 helps RNA polymerase II to overcome a nucleosomal barrier during elongation, in vivo. EMBO Rep 11: 751-757.
72. Richman D. D, Margolis D. M, Delaney M, Greene W. C, Hazuda D, et al. (2009) The challenge of finding a cure for HIV infection. Science 323: 1304-1307.